View in EDS

321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).

Saved in:
Bibliographic Details
Title: 321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).
Authors: Roderburg, C.1 (AUTHOR), Gonzalez Carmona, M.A.2 (AUTHOR), Berres, M-L.3 (AUTHOR), Modest, D.P.4 (AUTHOR), Mohr, R.5 (AUTHOR), Wree, A.6 (AUTHOR), Venerito, M.7 (AUTHOR), Keitel, V.8 (AUTHOR), Waldschmidt, D.T.9 (AUTHOR), Lüdde, T.10 (AUTHOR), Kehmann, L.11 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 1, Vol. 36, pS125-S125. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 186164207
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Roderburg%2C+C%2E%22">Roderburg, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonzalez+Carmona%2C+M%2EA%2E%22">Gonzalez Carmona, M.A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berres%2C+M-L%2E%22">Berres, M-L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohr%2C+R%2E%22">Mohr, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wree%2C+A%2E%22">Wree, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Venerito%2C+M%2E%22">Venerito, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keitel%2C+V%2E%22">Keitel, V.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Waldschmidt%2C+D%2ET%2E%22">Waldschmidt, D.T.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lüdde%2C+T%2E%22">Lüdde, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kehmann%2C+L%2E%22">Kehmann, L.</searchLink><relatesTo>11</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 1, Vol. 36, pS125-S125. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186164207
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.05.336
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S125
    Titles:
      – TitleFull: 321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roderburg, C.
      – PersonEntity:
          Name:
            NameFull: Gonzalez Carmona, M.A.
      – PersonEntity:
          Name:
            NameFull: Berres, M-L.
      – PersonEntity:
          Name:
            NameFull: Modest, D.P.
      – PersonEntity:
          Name:
            NameFull: Mohr, R.
      – PersonEntity:
          Name:
            NameFull: Wree, A.
      – PersonEntity:
          Name:
            NameFull: Venerito, M.
      – PersonEntity:
          Name:
            NameFull: Keitel, V.
      – PersonEntity:
          Name:
            NameFull: Waldschmidt, D.T.
      – PersonEntity:
          Name:
            NameFull: Lüdde, T.
      – PersonEntity:
          Name:
            NameFull: Kehmann, L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2025 Supplement 1
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1